ANGEL LUIS
GUERRERO PERAL
PROFESOR ASOCIADO CIENCIAS DE LA SALUD
Jesús
Porta Etessam
Publications dans lesquelles il/elle collabore avec Jesús Porta Etessam (30)
2024
-
CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability study in migraine
Cephalalgia : an international journal of headache, Vol. 44, Núm. 4
-
Effectiveness, tolerability, and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study
Pain Medicine (United States), Vol. 25, Núm. 3, pp. 194-202
-
Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti-calcitonin gene-related peptide therapies: The PREVENAC study
European Journal of Neurology, Vol. 31, Núm. 5
-
Observational Retrospective Study in Patients Treated with Galcanezumab as Preventive Treatment for Migraine: The ORYGAM Study
Pain and Therapy, Vol. 13, Núm. 3, pp. 557-576
2023
-
Diagnosis and treatment of trigeminal neuralgia: Consensus statement from the Spanish Society of Neurology's Headache Study Group
Neurologia, Vol. 38, pp. S37-S52
-
Evaluating the Impact of a Training Program in Shared Decision-Making for Neurologists Treating People with Migraine
Neurology and Therapy, Vol. 12, Núm. 4, pp. 1319-1334
-
Study about the Manchester Triage System subtriage in patients that visited the Emergency Department due to headache
Neurologia, Vol. 38, Núm. 4, pp. 270-277
-
Telemedicine in the management of patients with headache: current situation and recommendations of the Spanish Society of Neurology's Headache Study Group
Neurologia, Vol. 38, Núm. 9, pp. 635-646
2022
-
Adaptation and Validation of the Spanish Version of Decisional Conflict Scale in People with Migraine in Spain
Patient Preference and Adherence, Vol. 16, pp. 3291-3302
-
Calcitonin gene–related peptide in migraine: from pathophysiology to treatment
Neurologia, Vol. 37, Núm. 5, pp. 390-402
-
Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients
Cephalalgia, Vol. 42, Núm. 8, pp. 804-809
-
Sensitivity of the SNNOOP10 list in the high-risk secondary headache detection
Cephalalgia, Vol. 42, Núm. 14, pp. 1521-1531
2021
-
1st Post-European Headache Federation Meeting: A review of the latest developments presented at the 2020 European Headache Federation Congress
Revista de Neurologia
-
Document of revision and updating of medication overuse headache (MOH)
Neurologia, Vol. 36, Núm. 3, pp. 229-240
-
Failure to monoclonal antibodies against CGRP or its receptor does not preclude lack of efficacy to other drugs from the same therapeutic class
Neurologia
-
Management of thunderclap headache in the emergency room: A retrospective cohort study
Cephalalgia, Vol. 41, Núm. 6, pp. 711-720
-
Temporal distribution of emergency room visits in patients with migraine and other headaches
Expert Review of Neurotherapeutics, Vol. 21, Núm. 5, pp. 599-605
2020
-
Deep Phenotyping of Headache in Hospitalized COVID-19 Patients via Principal Component Analysis
Frontiers in Neurology, Vol. 11
-
Evidence of and experience with the use of onabotulinumtoxinA in trigeminal neuralgia and primary headaches other than chronic migraine
Neurologia, Vol. 35, Núm. 8, pp. 568-578
-
Frequency and Type of Red Flags in Patients With Covid-19 and Headache: A Series of 104 Hospitalized Patients
Headache, Vol. 60, Núm. 8, pp. 1664-1672